Related Experiment Video
Updated: Jun 19, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
THE ACTION OF A SPECIFIC ENZYME UPON THE DERMAL INFECTION OF RABBITS WITH TYPE III PNEUMOCOCCUS
Abstract:
The action of the enzyme which specifically decomposes the capsular polysaccharide of Type III Pneumococcus has been tested in Type III pneumococcus dermal infections in rabbits. When injected in sufficient amounts, this enzyme is capable of bringing about a favorable and early termination of the experimental disease which ordinarily is fatal in nearly all instances. The results of the present study yield further evidence that the capsular substance is of great importance in pneumococcus infection, since, in so far as known, the only action of which the specific enzyme is capable is that of decomposing the capsular polysaccharide.
Insights
An enzyme targeting Type III Pneumococcus polysaccharide capsules effectively treated dermal infections in rabbits. This enzyme demonstrated the critical role of capsular substances in pneumococcal disease progression and treatment.
Area of Science:
- Microbiology
- Enzymology
- Immunology
Background:
- Type III Pneumococcus infections pose a significant threat, often proving fatal.
- The capsular polysaccharide is a key virulence factor in pneumococcal infections.
Purpose of the Study:
- To evaluate the therapeutic potential of an enzyme that specifically degrades the Type III Pneumococcus capsular polysaccharide.
- To investigate the role of the capsular substance in the pathogenesis of pneumococcal infections.
Main Methods:
- Experimental dermal infections with Type III Pneumococcus were established in rabbits.
- A specific enzyme targeting the capsular polysaccharide was administered in sufficient quantities.
Main Results:
- The enzyme treatment led to a favorable and early termination of the experimental disease.
- The enzyme's action was directly correlated with the decomposition of the capsular polysaccharide.
- The treated infections showed a significant improvement compared to untreated, typically fatal, infections.
Conclusions:
- The enzyme holds therapeutic promise for Type III Pneumococcus infections.
- The study reinforces the critical importance of the capsular polysaccharide in pneumococcal pathogenesis.
- Targeting the capsular polysaccharide with specific enzymes represents a viable therapeutic strategy.
More Related Videos
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Determinants of Bacterial Pathogenicity and Virulence

